Editorial
doi: 10.1080/21505594.2016.1231756.
Epub 2016 Sep 3.
Using carbapenems for carbapenem-resistant Klebsiella pneumoniae-Are we flogging a dead (work)horse antibiotic?
Affiliations
- PMID: 27593359
- PMCID: PMC5354235
- DOI: 10.1080/21505594.2016.1231756
Item in Clipboard
Editorial
Using carbapenems for carbapenem-resistant Klebsiella pneumoniae-Are we flogging a dead (work)horse antibiotic?
Virulence.
.
No abstract available
Keywords: KPC carbapenemase; combination therapy; meropenem; synergy.
Comment on
-
Meropenem for treating KPC-producing Klebsiella pneumoniae bloodstream infections: Should we get to the PK/PD root of the paradox?Virulence. 2017 Jan 2;8(1):66-73. doi: 10.1080/21505594.2016.1213476. Epub 2016 Jul 18. Virulence. 2017. PMID: 27430122 Free PMC article.
Similar articles
-
In vitro evaluation of different antimicrobial combinations against carbapenemase-producing Klebsiella pneumoniae: the activity of the double-carbapenem regimen is related to meropenem MIC value.J Antimicrob Chemother. 2017 Jul 1;72(7):1981-1984. doi: 10.1093/jac/dkx084. J Antimicrob Chemother. 2017. PMID: 28369424
-
Modeling Meropenem Treatment, Alone and in Combination with Daptomycin, for KPC-Producing Klebsiella pneumoniae Strains with Unusually Low Carbapenem MICs.Antimicrob Agents Chemother. 2016 Jul 22;60(8):5047-50. doi: 10.1128/AAC.00168-16. Print 2016 Aug. Antimicrob Agents Chemother. 2016. PMID: 27216067 Free PMC article.
-
[Investigation of the susceptibilities of extended-spectrum beta-lactamase-producing Escherichia coli and Klebsiella spp. strains to ertapenem and other carbapenems].Mikrobiyol Bul. 2011 Jan;45(1):28-35. Mikrobiyol Bul. 2011. PMID: 21341156 Turkish.
-
Carbapenemase-producing Klebsiella pneumoniae: (when) might we still consider treating with carbapenems?Clin Microbiol Infect. 2011 Aug;17(8):1135-41. doi: 10.1111/j.1469-0691.2011.03553.x. Epub 2011 Jun 2. Clin Microbiol Infect. 2011. PMID: 21635663 Review.
-
The real threat of Klebsiella pneumoniae carbapenemase-producing bacteria.Lancet Infect Dis. 2009 Apr;9(4):228-36. doi: 10.1016/S1473-3099(09)70054-4. Lancet Infect Dis. 2009. PMID: 19324295 Review.
Cited by
-
Retrospective analysis of fosfomycin combinational therapy for sepsis caused by carbapenem-resistant Klebsiella pneumoniae.Exp Ther Med. 2017 Mar;13(3):1003-1010. doi: 10.3892/etm.2017.4046. Epub 2017 Jan 16. Exp Ther Med. 2017. PMID: 28450933 Free PMC article.
References
-
- European Antimicrobial Resistance Surveillance Network (EARS-Net) http://ecdc.europa.eu/en/healthtopics/antimicrobial_resistance/database/.... Accessed, August25, 2016.
-
- Pitout JDD, Nordmann P, Poirel L. Carbapenemase-Producing Klebsiella pneumoniae, a Key Pathogen Set for Global Nosocomial Dominance. Antimicrob Agents Chemother 2015; 59:5873-84; PMID:26169401; http://dx.doi.org/10.1128/AAC.01019-15 - DOI - PMC - PubMed
-
- Petrosillo N, Giannella M, Lewis R, Viale P. Treatment of carbapenem-resistant Klebsiella pneumoniae: the state of the art. Expert Rev Anti Infect Ther 2013; 11:159-77; PMID:23409822; http://dx.doi.org/10.1586/eri.12.162 - DOI - PubMed
-
- De Rosa FG, Corcione S, Cavallo R, Di Perri G, Bassetti M. Critical issues for Klebsiella pneumoniae KPC-carbapenemase producing K. pneumoniae infections: a critical agenda. Future Microbiol 2015; 10:283-94; PMID:25689539; http://dx.doi.org/10.2217/fmb.14.121 - DOI - PubMed
-
- Rafailidis PI, Falagas ME. Options for treating carbapenem-resistant Enterobacteriaceae. Curr Opin Infect Dis 2014; 27:479-83; PMID:25259809; http://dx.doi.org/10.1097/QCO.0000000000000109 - DOI - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
